Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Autoimmune Disorders01:29

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gut Microbiota and Metabolomic Changes In Type 2 Diabetes Mellitus: Insights From 16S rDNA Sequencing and Bioinformatics.

Journal of visualized experiments : JoVE·2026
Same author

Mineral elements-mediated responses govern cadmium accumulation in plants under C14 alkane stress.

Frontiers in microbiology·2026
Same author

Post-operative acute pain assessment and management in breast cancer patients: a best practice implementation project.

JBI evidence implementation·2026
Same author

Integrated transcriptomic and metabolomic investigation reveals that graphene oxide reduces nicosulfuron detriment in sweet corn.

Molecular genetics and genomics : MGG·2026
Same author

Oncofertility information interventions in patients with cancer: A systematic review and meta-analysis.

Asia-Pacific journal of oncology nursing·2026
Same author

Analysis of risk factors for primary non-central malposition of peripherally inserted central catheter tip in neonates with different diseases admitted to neonatal surgical department: a case-control study.

BMJ open·2026

Related Experiment Video

Updated: Jun 5, 2026

The bm12 Inducible Model of Systemic Lupus Erythematosus (SLE) in C57BL/6 Mice
12:04

The bm12 Inducible Model of Systemic Lupus Erythematosus (SLE) in C57BL/6 Mice

Published on: November 1, 2015

L2pB1: a new player in autoimmunity.

Xuemei Zhong1, Thomas L Rothstein

  • 1Hematology and Oncology Section, Department of Medicine, Boston University Medical Center, Boston, MA, USA. xuemei.zhong03@gmail.com

Molecular Immunology
|January 4, 2011
PubMed
Summary

Newly discovered PD-L2-positive B1 (L2pB1) cells exhibit self-reactive B cell receptor repertoires and promote autoimmunity. These L2pB1 cells are implicated in lupus pathogenesis, suggesting a role in autoimmune diseases.

Area of Science:

  • Immunology
  • Autoimmunity
  • Cell Biology

Background:

  • A novel subpopulation of B1 B cells, termed PD-L2-positive B1 (L2pB1) cells, has been identified.
  • L2pB1 cells express PD-L2 (CD273, B7-DC), a ligand for the inhibitory receptor PD-1, distinguishing them from PD-L2-negative B1 (L2nB1) cells.

Purpose of the Study:

  • To review the unique characteristics of L2pB1 cells.
  • To explore the potential role of L2pB1 cells in the pathophysiology of autoimmune diseases.

Main Methods:

  • Comparative analysis of L2pB1 and L2nB1 cell features.
  • Examination of L2pB1 cell numbers and autoantibody titers in murine lupus models.

Main Results:

  • L2pB1 cells share common B1 cell traits but possess a biased Ig repertoire enriched for self-reactivity.

More Related Videos

Murine Bilateral Renal Lymphadenectomy
06:31

Murine Bilateral Renal Lymphadenectomy

Published on: December 30, 2025

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
07:37

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice

Published on: June 6, 2025

Related Experiment Videos

Last Updated: Jun 5, 2026

The bm12 Inducible Model of Systemic Lupus Erythematosus (SLE) in C57BL/6 Mice
12:04

The bm12 Inducible Model of Systemic Lupus Erythematosus (SLE) in C57BL/6 Mice

Published on: November 1, 2015

Murine Bilateral Renal Lymphadenectomy
06:31

Murine Bilateral Renal Lymphadenectomy

Published on: December 30, 2025

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
07:37

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice

Published on: June 6, 2025

  • L2pB1 cells exhibit enhanced antigen presentation and isotype switching capabilities (IgM to IgG1/IgG2b).
  • Increased L2pB1 cell populations correlate with higher anti-dsDNA titers in lupus models.
  • Conclusions:

    • L2pB1 cells display distinct features, including self-reactivity and potent antigen presentation, suggesting a role in autoimmunity.
    • The increased presence of L2pB1 cells in lupus models highlights their potential pathophysiological contribution to autoimmune dyscrasias.